Unsecured Creditors Meeting Held for Dr. Agarwal's Health Care Scheme of Amalgamation
A meeting of the unsecured creditors of Dr. Agarwal's Health Care Limited regarding a scheme of amalgamation was convened on July 02, 2026, in Chennai. The proceedings were held to discuss the merger of Dr. Agarwal's Eye Hospital Limited (Transferor Company) with Dr. Agarwal's Health Care Limited (Transferee Company).The meeting was conducted at The Music Academy, T.T.K. Road, Chennai, and was chaired by Shri L N Gupta, as directed by the National Company Law Tribunal (NCLT). The purpose of the gathering was to address the Scheme of Amalgamation along with respective shareholders and creditors.
As per company records, Dr. Agarwal's Health Care Limited had a total of 996 Unsecured Creditors as of December 31, 2025. Despite this number, the meeting ultimately adjourned because the requisite quorum, set at a minimum of 30 Unsecured Creditors or their proxies, was not achieved.
The creditors were informed that the detailed Explanatory Statement and all supporting documents concerning the Scheme of Amalgamation were available for inspection. A primary resolution proposed during the meeting sought to consider and approve the Scheme of Amalgamation under Sections 230 to 232 of the Companies Act, 2013.
The voting process was organized using a combination of remote e-voting and physical polling papers for proxy holders present at the venue. The meeting concluded at 05:19 P.M. IST after the voting period ended. Shri Shivam Parashar was appointed as Scrutinizer to oversee the conduct of the voting process, which involved both virtual and on-site submissions.
The outcome of the meeting is recorded in the Summary of Proceedings for Dr. Agarwal's Health Care Limited.
AGARWALEYE Stock Price Movement
Dr. Agarwal's Health Care Limited shares rallied on Thursday, edging higher by 2.21% to settle at ₹476.60 in market trading. The equity saw a solid day of activity, with 66,499 shares traded and closing well above the previous close of ₹469.05.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.